Healthcare provider profile · identity verified

Brian T Oge, M.D.

Family Practice · NASHVILLE, AR · NPI 1972508984

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	593	130
Amlodipine Besylate	Amlodipine Besylate	571	133
Levothyroxine Sodium	Levothyroxine Sodium	443	81
Losartan Potassium	Losartan Potassium	404	84
Gabapentin	Gabapentin	349	68
Pantoprazole Sodium	Pantoprazole Sodium	340	66
Omeprazole	Omeprazole	332	70
Metoprolol Tartrate	Metoprolol Tartrate	281	54
Lisinopril	Lisinopril	278	63
Potassium Chloride	Potassium Chloride	260	71
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	233	27
Duloxetine Hcl	Duloxetine Hcl	205	35
Hydrochlorothiazide	Hydrochlorothiazide	200	51
Meloxicam	Meloxicam	197	45
Furosemide	Furosemide	192	56
Simvastatin	Simvastatin	170	35
Metoprolol Succinate	Metoprolol Succinate	149	34
Glipizide	Glipizide	148	35
Tamsulosin Hcl	Tamsulosin Hcl	144	29
Sertraline Hcl	Sertraline Hcl	140	28
Tramadol Hcl	Tramadol Hcl	139	33
Metformin Hcl	Metformin Hcl	136	34
Albuterol Sulfate Hfa	Albuterol Sulfate	131	38
Carvedilol	Carvedilol	125	32
Clopidogrel	Clopidogrel Bisulfate	125	28
Rosuvastatin Calcium	Rosuvastatin Calcium	118	25
Allopurinol	Allopurinol	116	28
Fluticasone Propionate	Fluticasone Propionate	116	49
Pravastatin Sodium	Pravastatin Sodium	113	27
Alprazolam	Alprazolam	107	21
Eliquis	Apixaban	96	21
Metformin Hcl Er	Metformin Hcl	91	19
Glipizide Er	Glipizide	90	17
Mirtazapine	Mirtazapine	90	20
Glimepiride	Glimepiride	86	18
Famotidine	Famotidine	79	18
Trazodone Hcl	Trazodone Hcl	79	14
Pregabalin	Pregabalin	78	12
Clonazepam	Clonazepam	77	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	75	15
Farxiga	Dapagliflozin Propanediol	73	15
Venlafaxine Hcl Er	Venlafaxine Hcl	73	suppressed
Donepezil Hcl	Donepezil Hcl	71	12
Spironolactone	Spironolactone	71	20
Montelukast Sodium	Montelukast Sodium	68	13
Nifedipine Er	Nifedipine	63	suppressed
Warfarin Sodium	Warfarin Sodium	62	suppressed
Buspirone Hcl	Buspirone Hcl	61	12
Temazepam	Temazepam	61	11
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	60	15
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	59	19
Diclofenac Sodium	Diclofenac Sodium	58	14
Levetiracetam	Levetiracetam	58	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	57	16
Citalopram Hbr	Citalopram Hydrobromide	56	11
Escitalopram Oxalate	Escitalopram Oxalate	56	12
Quetiapine Fumarate	Quetiapine Fumarate	55	11
Fluoxetine Hcl	Fluoxetine Hcl	54	suppressed
Memantine Hcl	Memantine Hcl	53	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	52	43
Alendronate Sodium	Alendronate Sodium	50	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	49	13
Propranolol Hcl	Propranolol Hcl	49	suppressed
Lorazepam	Lorazepam	48	suppressed
Sucralfate	Sucralfate	47	suppressed
Mounjaro	Tirzepatide	45	suppressed
Naproxen	Naproxen	45	suppressed
Finasteride	Finasteride	44	suppressed
Paroxetine Hcl	Paroxetine Hcl	44	suppressed
Atenolol	Atenolol	43	11
Hydralazine Hcl	Hydralazine Hcl	43	11
Tizanidine Hcl	Tizanidine Hcl	40	11
Methocarbamol	Methocarbamol	39	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	37	suppressed
Lovastatin	Lovastatin	37	11
Dicyclomine Hcl	Dicyclomine Hcl	36	suppressed
Trimethoprim	Trimethoprim	35	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	34	suppressed
Cefdinir	Cefdinir	33	29
Ropinirole Hcl	Ropinirole Hcl	33	suppressed
Januvia	Sitagliptin Phosphate	32	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	30	suppressed
Celecoxib	Celecoxib	30	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	29	24
Ondansetron Odt	Ondansetron	29	11
Tresiba Flextouch U-100	Insulin Degludec	29	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	28	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	28	18
Ozempic	Semaglutide	27	suppressed
Colchicine	Colchicine	26	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	26	suppressed
Fluconazole	Fluconazole	25	15
Xarelto	Rivaroxaban	25	suppressed
Levemir Flexpen	Insulin Detemir	24	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	24	suppressed
Novolog Mix 70-30 Flexpen	Insulin Aspart Prot/Insuln Asp	23	suppressed
Ramipril	Ramipril	23	suppressed
Acyclovir	Acyclovir	22	suppressed
Azithromycin	Azithromycin	22	21
Ezetimibe	Ezetimibe	21	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	21	suppressed
Klor-Con M20	Potassium Chloride	21	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	21	suppressed
Valsartan	Valsartan	21	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	20	suppressed
Lansoprazole	Lansoprazole	20	suppressed
Nebivolol Hcl	Nebivolol Hcl	20	suppressed
Risperidone	Risperidone	20	suppressed
Divalproex Sodium	Divalproex Sodium	19	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	19	suppressed
Ventolin Hfa	Albuterol Sulfate	19	11
Haloperidol	Haloperidol	18	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	18	suppressed
Lamotrigine	Lamotrigine	18	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	18	14
Spironolactone-Hctz	Spironolact/Hydrochlorothiazid	18	suppressed
Verapamil Er	Verapamil Hcl	18	suppressed
Enalapril-Hydrochlorothiazide	Enalapril/Hydrochlorothiazide	17	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	17	suppressed
Nystatin	Nystatin	17	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	17	14
Benazepril Hcl	Benazepril Hcl	16	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	16	suppressed
Midodrine Hcl	Midodrine Hcl	16	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	16	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	16	15
Synthroid	Levothyroxine Sodium	16	suppressed
Bupropion Xl	Bupropion Hcl	15	suppressed
Cephalexin	Cephalexin	15	14
Doxepin Hcl	Doxepin Hcl	15	suppressed
Prednisone	Prednisone	15	13
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	14	suppressed
Bupropion Hcl Sr	Bupropion Hcl	14	suppressed
Calcitonin-Salmon	Calcitonin,salmon,synthetic	14	suppressed
Clonidine Hcl	Clonidine Hcl	14	suppressed
Enalapril Maleate	Enalapril Maleate	14	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	14	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	14	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	13	12
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	13	suppressed
Metformin Er Osmotic	Metformin Hcl	13	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	13	suppressed
Ziprasidone Hcl	Ziprasidone Hcl	13	suppressed
Breo Ellipta	Fluticasone/Vilanterol	12	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	12	suppressed
Econazole Nitrate	Econazole Nitrate	12	suppressed
Fentanyl	Fentanyl	12	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	12	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	12	suppressed
Mesalamine Er	Mesalamine	12	suppressed
Mupirocin	Mupirocin	12	suppressed
Myrbetriq	Mirabegron	12	suppressed
Xtampza Er	Oxycodone Myristate	12	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	12	suppressed
Baclofen	Baclofen	11	suppressed
Humulin R	Insulin Regular, Human	11	suppressed
Ipratropium Bromide	Ipratropium Bromide	11	suppressed
Oxcarbazepine	Oxcarbazepine	11	suppressed
Spiriva Handihaler	Tiotropium Bromide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error